Raras
Buscar doenças, sintomas, genes...
Candidíase mucocutânea crônica
ORPHA:1334CID-10 · B37.2CID-11 · 1F23.14DOENÇA RARA

O Transdutor de sinal e ativador de transcrição 1 (STAT1) é um fator de transcrição que em humanos é codificado pelo gene STAT1. É um membro da família de proteínas STAT [en].

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Doença rara caracterizada por infecções fúngicas persistentes por *Candida* na pele e mucosas, associada a diversas manifestações autoimunes e inflamatórias. Pode apresentar dermatite eczematoide, infecções recorrentes e alterações em órgãos como pulmões e rins.

Pesquisas ativas
1 ensaio
5 total registrados no ClinicalTrials.gov
Publicações científicas
822 artigos
Último publicado: 2026 Apr 7

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Childhood
+ infancy
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: B37.2
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧬
Pele e cabelo
17 sintomas
🩸
Sangue
10 sintomas
🫃
Digestivo
9 sintomas
📏
Crescimento
9 sintomas
🛡️
Imunológico
8 sintomas
🫁
Pulmão
8 sintomas

+ 38 sintomas em outras categorias

Características mais comuns

90%prev.
Queilite
Muito frequente (99-80%)
90%prev.
Erupção cutânea
Muito frequente (99-80%)
90%prev.
Morfologia anormal da unha
Muito frequente (99-80%)
90%prev.
Eritema
Muito frequente (99-80%)
90%prev.
Morfologia anormal do lábio
Muito frequente (99-80%)
90%prev.
Infecções recorrentes
Muito frequente (99-80%)
123sintomas
Muito frequente (14)
Frequente (3)
Ocasional (14)
Sem dados (92)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 123 características clínicas mais associadas, ordenadas por frequência.

QueiliteCheilitis
Muito frequente (99-80%)90%
Erupção cutâneaSkin rash
Muito frequente (99-80%)90%
Morfologia anormal da unhaAbnormality of the nail
Muito frequente (99-80%)90%
EritemaErythema
Muito frequente (99-80%)90%
Morfologia anormal do lábioAbnormal lip morphology
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico822PubMed
Últimos 10 anos200publicações
Pico202144 papers
Linha do tempo
2026Hoje · 2026🧪 2012Primeiro ensaio clínico📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

6 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive.

IL17RAInterleukin-17 receptor ADisease-causing germline mutation(s) inTolerante
FUNÇÃO

Receptor for IL17A and IL17F, major effector cytokines of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity. Receptor for IL17A (PubMed:17911633, PubMed:9367539). Receptor for IL17F (PubMed:17911633, PubMed:19838198). Binds to IL17A with higher affinity than to IL17F (PubMed:17911633). Binds IL17A and IL17F homodimers as part of a heterodimeric complex with IL17RC (PubMed:16785495). Also binds heterodimers formed by IL17A and IL17F as pa

LOCALIZAÇÃO

Cell membraneSecreted

VIAS BIOLÓGICAS (2)
SARS-CoV-2 activates/modulates innate and adaptive immune responsesInterleukin-17 signaling
MECANISMO DE DOENÇA

Immunodeficiency 51

A primary immunodeficiency disorder with altered immune responses and impaired clearance of fungal infections, selective against Candida. It is characterized by persistent and/or recurrent infections of the skin, nails and mucous membranes caused by organisms of the genus Candida, mainly Candida albicans.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
75.9 TPM
Baço
30.1 TPM
Pulmão
22.6 TPM
Fibroblastos
19.2 TPM
Tecido adiposo
17.2 TPM
OUTRAS DOENÇAS (2)
immunodeficiency 51chronic mucocutaneous candidiasis
HGNC:5985UniProt:Q96F46
STAT1Signal transducer and activator of transcription 1-alpha/betaDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Signal transducer and transcription activator that mediates cellular responses to interferons (IFNs), cytokine KITLG/SCF and other cytokines and other growth factors (PubMed:12764129, PubMed:12855578, PubMed:15322115, PubMed:23940278, PubMed:34508746, PubMed:35568036, PubMed:9724754). Following type I IFN (IFN-alpha and IFN-beta) binding to cell surface receptors, signaling via protein kinases leads to activation of Jak kinases (TYK2 and JAK1) and to tyrosine phosphorylation of STAT1 and STAT2.

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (10)
Interferon alpha/beta signalingSARS-CoV-2 activates/modulates innate and adaptive immune responsesPKR-mediated signalingInterleukin-20 family signalingInterleukin-6 signaling
MECANISMO DE DOENÇA

Immunodeficiency 31B

A disorder characterized by susceptibility to severe mycobacterial and viral infections. Affected individuals can develop disseminated infections and die of viral illness.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
501.4 TPM
Fibroblastos
236.5 TPM
Pulmão
63.5 TPM
Baço
61.7 TPM
Aorta
51.6 TPM
OUTRAS DOENÇAS (3)
immunodeficiency 31Bautoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndromeMendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency
HGNC:11362UniProt:P42224
IL17RCInterleukin-17 receptor CDisease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Receptor for IL17A and IL17F, major effector cytokines of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity (By similarity). Receptor for IL17A and IL17F, major effector cytokines of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity. Receptor for IL17A and IL17F homodimers as part of a heterodimeric complex with IL17RA (PubMed:16785495). Receptor for the heterodimer formed by IL1

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Interleukin-17 signalingSARS-CoV-2 activates/modulates innate and adaptive immune responses
MECANISMO DE DOENÇA

Candidiasis, familial, 9

A disorder characterized by altered immune responses and impaired clearance of fungal infections, selective against Candida. It is characterized by persistent and/or recurrent infections of the skin, nails and mucous membranes caused by organisms of the genus Candida, mainly Candida albicans.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
122.0 TPM
Próstata
98.0 TPM
Cólon sigmoide
79.5 TPM
Skin Not Sun Exposed Suprapubic
78.6 TPM
Skin Sun Exposed Lower leg
74.7 TPM
OUTRAS DOENÇAS (2)
candidiasis, familial, 9chronic mucocutaneous candidiasis
HGNC:18358UniProt:Q8NAC3
CLEC7AC-type lectin domain family 7 member ADisease-causing germline mutation(s) inTolerante
FUNÇÃO

Lectin that functions as a pattern recognizing receptor (PRR) specific for beta-1,3-linked and beta-1,6-linked glucans, which constitute cell wall constituents from pathogenic bacteria and fungi (PubMed:11567029, PubMed:12423684). Necessary for the TLR2-mediated inflammatory response and activation of NF-kappa-B: upon beta-glucan binding, recruits SYK via its ITAM motif and promotes a signaling cascade that activates some CARD domain-BCL10-MALT1 (CBM) signalosomes, leading to the activation of N

LOCALIZAÇÃO

Cell membraneCytoplasm

VIAS BIOLÓGICAS (1)
CLEC7A (Dectin-1) signaling
MECANISMO DE DOENÇA

Candidiasis, familial, 4

A primary immunodeficiency disorder with altered immune responses and impaired clearance of fungal infections, selective against Candida. It is characterized by persistent and/or recurrent infections of the skin, nails and mucous membranes caused by organisms of the genus Candida, mainly Candida albicans.

OUTRAS DOENÇAS (3)
candidiasis, familial, 4chronic mucocutaneous candidiasisaspergillosis, susceptibility to
HGNC:14558UniProt:Q9BXN2
IL17FInterleukin-17FDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Effector cytokine of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity (PubMed:21350122). IL17A-IL17F signals via IL17RA-IL17RC heterodimeric receptor complex, triggering homotypic interaction of IL17RA and IL17RC chains with TRAF3IP2 adapter through SEFIR domains. This leads to downstream TRAF6-mediated activation of NF-kappa-B and MAPkinase pathways ultimately resulting in transcriptional activation of cytokines, chemokines, antimicrob

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (3)
Interleukin-17 signalingSARS-CoV-2 activates/modulates innate and adaptive immune responsesInterleukin-4 and Interleukin-13 signaling
MECANISMO DE DOENÇA

Candidiasis, familial, 6

A primary immunodeficiency disorder with altered immune responses and impaired clearance of fungal infections, selective against Candida. It is characterized by persistent and/or recurrent infections of the skin, nails and mucous membranes caused by organisms of the genus Candida, mainly Candida albicans.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
1.2 TPM
Cerebelo
0.1 TPM
Brain Nucleus accumbens basal ganglia
0.0 TPM
OUTRAS DOENÇAS (2)
candidiasis, familial, 6chronic mucocutaneous candidiasis
HGNC:16404UniProt:Q96PD4
TRAF3IP2E3 ubiquitin ligase TRAF3IP2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

E3 ubiquitin ligase that catalyzes 'Lys-63'-linked polyubiquitination of target protein, enhancing protein-protein interaction and cell signaling (PubMed:19825828). Transfers ubiquitin from E2 ubiquitin-conjugating enzyme UBE2V1-UBE2N to substrate protein (PubMed:19825828). Essential adapter molecule in IL17A-mediated signaling (PubMed:19825828, PubMed:24120361). Upon IL17A stimulation, interacts with IL17RA and IL17RC receptor chains through SEFIR domains and catalyzes 'Lys-63'-linked polyubiqu

LOCALIZAÇÃO

MECANISMO DE DOENÇA

Psoriasis 13

A common, chronic inflammatory disease of the skin with multifactorial etiology. It is characterized by red, scaly plaques usually found on the scalp, elbows and knees. These lesions are caused by abnormal keratinocyte proliferation and infiltration of inflammatory cells into the dermis and epidermis.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
27.5 TPM
Skin Sun Exposed Lower leg
26.6 TPM
Skin Not Sun Exposed Suprapubic
23.6 TPM
Cervix Ectocervix
22.6 TPM
Cervix Endocervix
21.7 TPM
OUTRAS DOENÇAS (3)
candidiasis, familial, 8chronic mucocutaneous candidiasispsoriasis 13, susceptibility to
HGNC:1343UniProt:O43734

Variantes genéticas (ClinVar)

336 variantes patogênicas registradas no ClinVar.

🧬 IL17RA: NM_014339.7(IL17RA):c.424-90G>A ()
🧬 IL17RA: NM_014339.7(IL17RA):c.650dup (p.Arg218fs) ()
🧬 IL17RA: NM_014339.7(IL17RA):c.51del (p.Leu18fs) ()
🧬 IL17RA: NM_014339.7(IL17RA):c.931+2T>G ()
🧬 IL17RA: NM_014339.7(IL17RA):c.112_119del (p.His38fs) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 8 variantes classificadas pelo ClinVar.

3
3
2
Patogênica (37.5%)
VUS (37.5%)
Benigna (25.0%)
VARIANTES MAIS SIGNIFICATIVAS
IL17RA: NM_014339.7(IL17RA):c.599-1G>A [Likely pathogenic]
STAT1: NM_007315.4(STAT1):c.884C>A (p.Thr295Lys) [Pathogenic]
STAT1: NM_007315.4(STAT1):c.800C>T (p.Ala267Val) [Pathogenic]
CLEC7A: NM_197947.3(CLEC7A):c.665G>A (p.Trp222Ter) [Uncertain significance]
CLEC7A: NM_197947.3(CLEC7A):c.536T>C (p.Phe179Ser) [Uncertain significance]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 31
2Fase 21
1Fase 11
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 4 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Candidíase mucocutânea crônica

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

5 ensaios clínicos encontrados, 1 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
329 papers (10 anos)
#1

IL-17-mediated antifungal immunity restricts Candida albicans pathogenicity in the oral cavity.

Nature microbiology2026 Jan

Candida albicans is a common resident of the microbiota that supports host homeostasis but can cause disease when immune defences are impaired. Mucocutaneous candidiasis in individuals with IL-17 immune defects provides insights into the immune system's role in controlling C. albicans. Here, using a murine model of oral colonization, we show that IL-17 signalling maintains C. albicans in a non-pathogenic state. Loss of IL-17 leads to fungal filamentation and upregulation of hyphae-associated genes, which is accompanied by epithelial barrier disruption and inflammation, linked to aberrant IL-22 and IL-13 production. The emergence of pathogenic fungal traits was associated with impaired zinc chelation due to reduced calprotectin expression in the IL-17-deficient mice. Prolonged exposure to the immune-dysregulated tissue led to selection of stable, damage-inducing C. albicans variants, mirroring the evolution of isolates from a chronic mucocutaneous candidiasis patient. These findings reveal how IL-17 protects against fungal pathogenicity and how immune dysfunction fosters C. albicans adaptation and diversification within the host.

#2

Genotype-Phenotype Delineation of Autoimmune Polyendocrinopathy, Candidiasis, and Ectodermal Dystrophy in a Pediatric Patient: A Case Report.

Genes2026 Jan 29

Autoimmune Polyendocrinopathy with Candidiasis and Ectodermal Dystrophy is an extremely rare autosomal recessive disorder caused by inborn errors of immunity. It is due to a loss-of-function mutation in the AIRE autoimmune regulator gene. Its manifestations include autoimmunity affecting endocrine glands, in addition to non-endocrine manifestations including dental enamel hypoplasia, alopecia areata, hepatitis, and chronic mucocutaneous candidiasis. Globally, 10 cases per million are affected by this condition, with higher incidence in highly consanguineous populations. Here, we describe a novel AIRE gene mutation in a pediatric patient from Lebanon, along with the observed phenotype. A nine-year-old boy with history of craniosynostosis presented with jaundice. His past medical history was significant for recurrent oral thrush, keratoconjunctivitis, nail dystrophy, and alopecia. Upon presentation, he had jaundice, isolated splenomegaly, and severe failure to thrive. Laboratory tests showed transaminitis, cholestasis, and hypergammaglobulinemia. Abdominal ultrasound findings were suggestive of cirrhosis with compensated portal hypertension. The differential diagnosis included viral infection, inborn errors of metabolism, and autoimmune hepatitis. Exome sequencing identified a novel homozygous pathogenic variant in the AIRE gene, NM_000383.4: c.1066dup p.(Arg356Profs*16), confirming the diagnosis. This study expands the genotypic and phenotypic spectrum of a rare inborn error of immunity in a child with chronic mucocutaneous candidiasis, enamel hypoplasia, and hepatitis.

#3

When One Gland Speaks First: Autoimmune Polyendocrinopathy Syndrome Type 1 (APS-1) Unmasked by Isolated Hypoparathyroidism.

Cureus2026 Jan

Autoimmune polyendocrinopathy syndrome type 1 (APS-1) is a rare autosomal recessive disorder caused by pathogenic variants in the AIRE gene and classically characterized by the triad of hypoparathyroidism, chronic mucocutaneous candidiasis, and adrenal insufficiency. Although hypoparathyroidism is often the earliest manifestation, isolated and prolonged monosymptomatic presentations remain uncommon and may delay recognition of the syndrome. We report the case of a child who was first presented at four years of age with severe hypocalcemia in the setting of acute gastroenteritis and was diagnosed with hypoparathyroidism. Apart from hypomagnesemia and hyperphosphatemia, extensive workup revealed no additional autoimmune or endocrine abnormalities. Genetic testing subsequently identified a homozygous likely pathogenic stop-loss AIRE gene mutation, confirming APS-1. Over a three-year follow-up period, the patient remained clinically stable with well-controlled hypoparathyroidism, except for hypocalcemic episodes during diarrheal illnesses, and persistently normal adrenal, thyroid, pancreatic, and celiac screening. The first additional disease feature emerged three years after the initial presentation, at the age of seven years, when a fungal nail infection consistent with mucocutaneous candidiasis was noted. This case highlights the marked phenotypic variability with delayed evolution of APS-1 and underscores that isolated hypoparathyroidism, even when severe, may precede other disease components by several years. Early genetic testing in children with apparently isolated hypoparathyroidism allows anticipatory guidance, structured surveillance, and timely recognition of evolving autoimmune manifestations.

#4

Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a case series and experience from a UK tertiary paediatric hospital.

Journal of pediatric endocrinology &amp; metabolism : JPEM2026 Feb 20

Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) is a multi-system autoimmune disorder caused by AIRE gene variants. Diagnosis can be challenging and often delayed. A specialised clinic for children and young people with APECED established in 2024 at Bristol Royal Hospital for Children, recruited patients from South-West England. We describe the diagnostic journey, disease progression and management challenges for 4 patients with APECED. All cases had a history of fungal nail infections and chronic mucocutaneous candidiasis preceding the development of endocrinopathy. Hypoparathyroidism was the most common endocrine presentation (n=3). Two patients had pancreatic exocrine dysfunction requiring pancreatic enzyme replacement. One patient had primary ovarian insufficiency (POI) aged 11. One female without evidence of POI was referred to fertility services to discuss fertility preservation. Immunomodulation was used in 2 patients; 1 received sirolimus, rituximab, corticosteroids, mycophenolate followed by ruxolitinib and 1 patient recently started ruxolitinib. Inter-speciality working is important to detect and manage a range of comorbidities as new immunomodulatory therapies that aim to prevent disease progression are emerging. Proactive screening for certain autoantibodies such as 21-OH can help predict patients at risk of certain endocrinopathies and may provide an opportunity for early intervention to prevent long-term morbidity.

#5

Long-term follow-up of autoimmune polyendocrine syndrome type-1 in Norway.

The Journal of clinical endocrinology and metabolism2026 Feb 12

Autoimmune polyendocrine syndrome type-1 (APS-1) is a rare, yet severe multiorgan autoimmune disease caused by mutations in the Autoimmune Regulator (AIRE) gene. Classical APS-1 arises from biallelic recessive AIRE mutations, whereas dominant negative mutations cause a milder, non-classical phenotype with variable clinical presentation. Due to its rarity, long-term, population-based data are limited, underscoring the need for extended follow-up to guide lifelong care and research. To characterize the clinical profiles of APS-1 and explore associations between disease manifestations, autoantibody profiles, and AIRE mutations over an extended follow-up (1996-2025). All known Norwegian patients with APS-1. We analysed longitudinal clinical and laboratory data of 71 APS-1 patients (49 classical, 22 non-classical) from the Norwegian Registry of Organ-specific Autoimmune Diseases. Data included clinical progression, autoantibody and cytokine profiles, and AIRE genotypes. Additionally, we compared age at diagnosis of primary adrenal insufficiency (PAI) in patients with and without (n=999) APS-1. In classical APS-1, the most frequent clinical manifestations were chronic mucocutaneous candidiasis, enamel hypoplasia, and PAI, while for non-classical APS-1 vitiligo, hypothyroidism, and PAI were most common. A broad pro-inflammatory cytokine signature was observed in classical APS-1, along with increased levels of the soluble form of the IFN-α/β receptor. APS-1 should be considered in patients diagnosed with PAI before age 20, and AIRE sequencing is recommended for diagnostic confirmation. The presence of IFN-ω autoantibodies, a pro-inflammatory cytokine profile, and increased soluble IFN receptor levels further support the role of dysregulated interferon responses in APS-1 pathogenesis.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC380 artigos no totalmostrando 197

2026

Genotype-Phenotype Delineation of Autoimmune Polyendocrinopathy, Candidiasis, and Ectodermal Dystrophy in a Pediatric Patient: A Case Report.

Genes
2026

When One Gland Speaks First: Autoimmune Polyendocrinopathy Syndrome Type 1 (APS-1) Unmasked by Isolated Hypoparathyroidism.

Cureus
2026

Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a case series and experience from a UK tertiary paediatric hospital.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2026

Long-term follow-up of autoimmune polyendocrine syndrome type-1 in Norway.

The Journal of clinical endocrinology and metabolism
2025

A novel heterozygous pathogenic AIRE variant causing autoimmunity but not infectious susceptibility.

Journal of human immunity
2026

Decreased IL-17-producing TH cells as a diagnostic marker for STAT signaling-related primary immunodeficiencies.

The journal of allergy and clinical immunology. Global
2025

CARD9 Mutations in Patients with Invasive Fungal Infections.

Mycopathologia
2025

The T385M STAT1 gain-of-function mutation confers the most severe disease outcomes.

Frontiers in immunology
2026

IL-17-mediated antifungal immunity restricts Candida albicans pathogenicity in the oral cavity.

Nature microbiology
2025

Systematic and proactive evaluation of AIRE missense variant effects.

bioRxiv : the preprint server for biology
2025

Clinical and Immunological Impact of JAK Inhibition in Concurrent Down Syndrome and STAT1 Gain of Function.

Journal of clinical immunology
2026

The Skin Tells the Story: Early Signs of Inborn Errors of Immunity.

The journal of allergy and clinical immunology. In practice
2025

Defects in Innate and Intrinsic Immunity in Morocco: A Retrospective Analysis of the Genetic Landscape and Clinical Correlations.

Pathogens &amp; immunity
2025

Case Report: Clinical and molecular features of a radiosensitive autoimmune polyendocrine syndrome type 1 patient with oral carcinoma.

Frontiers in genetics
2025

Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridging.

Journal of human immunity
2025

Case Report: Dual molecular diagnosis of gain-of-function STAT1 mutation and regulatory STAT3 variant in a patient with a hyper-IgE-like phenotype.

Frontiers in immunology
2025

Abundant Yet Aberrant T Helper Cell Responses to Candida albicans Underlie Mucosal Candidiasis in Humans and Mice.

European journal of immunology
2025

A Child with Chronic Mucocutaneous Candidiasis Harbors a Novel Gain-of-Function Mutation in STAT1.

Journal of clinical immunology
2025

Head and Neck Malignancies in Autoimmune Polyendocrine Syndrome Type 1 (APS-1/APECED): A Scoping Review of Molecular Pathogenesis, Clinical Features, and Outcomes.

International journal of molecular sciences
2025

Case Report: Life-threatening overlap of hemophagocytic syndrome and atypical hemolytic uremic syndrome in a patient with autoimmune polyglandular syndrome type 1 successfully treated with targeted immunotherapy.

Frontiers in immunology
2025

A Norwegian cohort with STAT1-related disease - further expanding the clinical phenotype.

Frontiers in immunology
2025

RELA Haploinsufficiency Manifesting as an Atypical Phenotype of Crohn's Disease.

Inflammatory bowel diseases
2025

Refractory mediastinal pyogenic lymphadenitis in a patient with chronic mucocutaneous candidiasis.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
2025

Clinical manifestations and treatment of STAT-1 gain-of-function: A single-center experience from India.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
2025

Homozygosity for the Common IL23R R381Q Variant Associates with Increased Susceptibility to Chronic Mucocutaneous Candidiasis.

European journal of immunology
2025

A Rare Case of Refractory Epilepsy Associated With Brain Calcifications and Mucocutaneous Candidiasis.

Cureus
2025

High-resolution transcriptional impact of AIRE: effects of pathogenic variants p.Arg257Ter, p.Cys311Tyr, and polygenic risk variant p.Arg471Cys.

Frontiers in immunology
2025

Pernicious Anemia in a Pediatric Patient With Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy.

JCEM case reports
2025

Amyloidosis in Human Inborn Errors of Immunity Predicts Poor Prognosis.

Journal of clinical immunology
2025

Autoimmune hyperglycemia: beyond type 1 diabetes.

Acta diabetologica
2025

Renal disorders in Autoimmune Polyendocrinopathy Candidiasis Ectodermal dystrophy (APECED): a systematic review.

BMC pediatrics
2024

Deciphering the role of IL17RA in psoriasis and chronic mucocutaneous candidiasis: shared pathways and distinct manifestations.

Frontiers in immunology
2024

Chronic mucocutaneous candidiasis, mycobacterial infections and rosacea in a Mexican adult with STAT1 gain of function.

Biomedica : revista del Instituto Nacional de Salud
2024

Recurrent Enteritis and Intestinal Obstruction in a Patient with Chronic Mucocutaneous Candidiasis due to STAT1 Gain-of-Function Mutation.

Mycopathologia
2024

Chronic mucocutaneous candidiasis due to signal transducer and activator of transcription 1 mutation in a Saudi patient: a case report.

Dermatology reports
2025

Coinfection of Leprosy and Chronic Mucocutaneous Candidiasis in a Family with STAT1 Gain-of-Function Mutation.

The American journal of tropical medicine and hygiene
2024

STAT1 and STAT3 gain of function: clinically heterogenous immune regulatory disorders.

Current opinion in allergy and clinical immunology
2024

A Novel Monoallelic Small Deletion Confers Gain-of-Function of STAT1 in a Child with Candidiasis and Mycobacterial Diseases.

Journal of clinical immunology
2024

Whitaker syndrome: A case report of autoimmune polyendocrine syndrome type 1 with dilated cardiomyopathy.

Clinical case reports
2024

Partial Lipodystrophy Affecting the Extremities in a Young Woman With Autoimmune Polyglandular Syndrome 1.

JCEM case reports
2024

Reduction in mucosal-associated invariant T cells (MAIT) in APECED patients is associated with elevated serum IFN-γ concentration.

European journal of immunology
2025

Recalcitrant extensive dermatophytosis in twin brothers with APECED syndrome.

Pediatric dermatology
2024

STAT1 Gain-of-Function Mutation in Chronic Mucocutaneous Candidiasis.

Indian journal of pediatrics
2024

Immunophenotyping and Therapeutic Insights from Chronic Mucocutaneous Candidiasis Cases with STAT1 Gain-of-Function Mutations.

Journal of clinical immunology
2024

Clinical and Biological Perspectives on Noncanonical Esophageal Squamous Cell Carcinoma in Rare Subtypes.

The American journal of gastroenterology
2024

Retrospective identification of the first cord blood-transplanted severe aplastic anemia in a STAT1-associated chronic mucocutaneous candidiasis family: case report, review of literature and pathophysiologic background.

Frontiers in immunology
2024

An uncommon presentation of autoimmune polyglandular syndrome type 1 (APS-1)-A case report.

Clinical case reports
2024

Qualitative Immunoglobulin Deficiency Causes Bacterial Infections in Patients with STAT1 Gain-of-Function Mutations.

Journal of clinical immunology
2024

Chinese Chronic Mucocutaneous Candidiasis: A Case Report Series.

Infection and drug resistance
2024

A novel mutation site in STAT in a chronic mucocutaneous candidiasis pediatric patient with disseminated cryptococcosis: Case report and review of the literature.

Pediatric discovery
2024

Long-term remission of candidiasis with fermented lingonberry mouth rinse in an adult patient with APECED.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2025

Lessons From Prospective Longitudinal Follow-up of a French APECED Cohort.

The Journal of clinical endocrinology and metabolism
2024

Chronic Mucocutaneous Candidiasis Due to STAT1 Gene Variant.

JAMA dermatology
2024

Patients with STAT1 Gain-of-function Mutations Display Increased Apoptosis which is Reversed by the JAK Inhibitor Ruxolitinib.

Journal of clinical immunology
2024

Early recognition of the APECED rash can accelerate the diagnosis of APECED.

Clinical immunology communications
2024

Patients with recurrent vulvovaginal candidiasis exhibit a decrease in both the fungicidal activity of neutrophils and the proliferation of peripheral blood mononuclear cells.

Mycoses
2024

Novel homozygous mutations in AIRE leading to APS-1 and potential mechanisms based on bioinformatics analysis.

Heliyon
2024

Mucocutaneous Candidiasis: Insights Into the Diagnosis and Treatment.

The Pediatric infectious disease journal
2024

CARD9 mutations in patients with fungal infections: An update from the last 5 years.

Mycoses
2024

Isolated Cutaneous Granuloma Caused by Candida Parapsilosis: Case Report and Literature Review.

Mycopathologia
2024

Increased type 1 inflammation in gynecologic cervicovaginal samples in patients with APS-1.

The Journal of allergy and clinical immunology
2024

Progress in molecular diagnosis and treatment of chronic mucocutaneous candidiasis.

Frontiers in immunology
2024

Cutaneous Manifestations in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED): A Comprehensive Review.

Biomedicines
2023

Novel STAT1 mutation in a paediatric case of chronic mucocutaneous candidiasis complicated by primary hypothyroidism: clinical presentation, genetic analysis and prognostic implications.

BMJ case reports
2023

Isolated Chronic Mucocutaneous Candidiasis due to a Novel Duplication Variant of IL17RC.

Journal of clinical immunology
2024

Human STAT1 gain of function with chronic mucocutaneous candidiasis: A comprehensive review for strengthening the connection between bedside observations and laboratory research.

Immunological reviews
2025

Early-onset Chronic Keratitis as the First Presenting Component of Autoimmune Polyendocrine Syndrome Type 1: A Case Report and Review of the Literature.

Journal of clinical research in pediatric endocrinology
2023

Innate Error Immunities of the Th17 Immune Pathway Associated With Chronic Mucocutaneous Candidiasis: A Systematic Review.

Journal of drugs in dermatology : JDD
2024

Concurrent infection of Exophiala dermatitidis and Angiostrongylus cantonensis in central nervous system of a child with inherited CARD9 deficiency: A case report and literature review.

Journal de mycologie medicale
2023

Mendelian susceptibility to mycobacterial diseases: State of the puzzle.

Qatar medical journal
2024

JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study.

The Journal of allergy and clinical immunology
2023

A partial form of AIRE deficiency underlies a mild form of autoimmune polyendocrine syndrome type 1.

The Journal of clinical investigation
2023

Cutaneous Mucormycosis and Fusariosis in a Chinese Woman with CARD9 Deficiency.

Mycopathologia
2024

STAT1 Mutations in Chronic Mucocutaneous Candidiasis Diagnosed in an Adult.

Internal medicine (Tokyo, Japan)
2023

Lymphadenitis caused by Purpureocillium lilacinum in a patient with CARD9 deficiency.

Medical mycology case reports
2024

CARD9 deficiency aggravated nonalcoholic steatohepatitis in mice through increasing inflammatory response.

Biochimica et biophysica acta. Molecular basis of disease
2023

Anticytokine Autoantibodies and Fungal Infections.

Journal of fungi (Basel, Switzerland)
2023

Genetic inhibition of CARD9 accelerates the development of atherosclerosis in mice through CD36 dependent-defective autophagy.

Nature communications
2023

Analysis of a series of Italian APECED patients with autoimmune hepatitis and gastro-enteropathies.

Frontiers in immunology
2023

Chronic mucocutaneous candidiasis due to STAT1 gene mutation.

The Journal of dermatology
2023

Knowledge mapping of COVID-19 and autoimmune diseases: a visual and bibliometric analysis.

Clinical and experimental medicine
2023

Chronic mucocutaneous candidiasis presenting as refractory fissured tongue in a patient with IL-17RC mutation: the first reported case of Chinese ethnicity.

Emerging microbes &amp; infections
2023

Neutrophils in STAT1 Gain-Of-Function Have a Pro-inflammatory Signature Which Is Not Rescued by JAK Inhibition.

Journal of clinical immunology
2023

A Novel Interleukin 17 Receptor A Mutation in a Child with Chronic Mucocutaneous Candidiasis and Staphylococcal Skin Infections.

Turkish archives of pediatrics
2023

Successful Rezafungin Treatment of an Azole-Resistant Chronic Mucocutaneous Candidiasis in a STAT-1 Gain-of-Function Patient.

Journal of clinical immunology
2023

Case for diagnosis. Disseminated erythematous and scaly plaques: chronic mucocutaneous candidiasis.

Anais brasileiros de dermatologia
2023

Quality of life in women with chronic recurrent vulvovaginal candidosis: A sub-analysis of the prospective multicentre phase IIb/III Prof-001 study.

Mycoses
2023

SARS-CoV-2-induced adrenal crisis in a patient with autoimmune polyglandular syndrome type 1: case report.

Folia medica
2023

An Extraordinary Case of Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED) Syndrome Misdiagnosed as Juvenile Idiopathic Arthritis on Admission.

Case reports in immunology
2023

The Th17/IL-17 Axis and Host Defense Against Fungal Infections.

The journal of allergy and clinical immunology. In practice
2023

CARD9 deficiency promotes pancreatic cancer growth by blocking dendritic cell maturation via SLC6A8-mediated creatine transport.

Oncoimmunology
2023

A Rare Case of Autoimmune Polyendocrinopathy-candidiasis-ectodermal Dystrophy Syndrome: Dental Perspective on Diagnosis and Management.

International journal of clinical pediatric dentistry
2023

Case report: Myocarditis in congenital STAT1 gain-of function.

Frontiers in immunology
2023

A Novel Homozygous Mutation of AIRE Gene in a Patient With Autoimmune Polyglandular Syndrome Type I.

Cureus
2023

Unusual Talaromyces marneffei and Pneumocystis jirovecii coinfection in a child with a STAT1 mutation: A case report and literature review.

Frontiers in immunology
2023

Heterozygous gain-of-function mutations in human STAT1: A case of hemophagocytic lymphohistiocytosis due to chronic mucocutaneous candidiasis in a 17-month-old male.

Pediatric blood &amp; cancer
2023

Case report: Discovery of a de novo FAM111B pathogenic variant in a patient with an APECED-like clinical phenotype.

Frontiers in immunology
2023

A family with interleukin-17 receptor A deficiency: a case report and review of the literature.

The Turkish journal of pediatrics
2023

Human IL-23 is essential for IFN-γ-dependent immunity to mycobacteria.

Science immunology
2023

Practical challenges for functional validation of STAT1 gain of function genetic variants.

Clinical and experimental immunology
2023

Chronic Mucocutaneous Candidiasis: A Case Report.

Clinical, cosmetic and investigational dermatology
2023

Characterisation of APS-1 Experimental Models Is Crucial for Development of Novel Therapies.

BioMed research international
2022

Autosomal dominant chronic mucocutaneous candidiasis with STAT1 mutation can be associated with chronic active hepatitis: A case report.

Frontiers in pediatrics
2023

Successful application of photodynamic therapy for skin infection caused by Corynespora cassiicola in an immunosuppressed patient and literature review.

Photodiagnosis and photodynamic therapy
2022

Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experience.

Frontiers in immunology
2022

Candida albicans V132 induces trained immunity and enhances the responses triggered by the polybacterial vaccine MV140 for genitourinary tract infections.

Frontiers in immunology
2023

Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome.

Journal of clinical immunology
2023

Inborn errors of immunity with loss- and gain-of-function germline mutations in STAT1.

Clinical and experimental immunology
2022

Chronic Mucocutaneous Candidiasis in An 11-Year-Old Child - A Case Report from South India.

Indian journal of dermatology
2023

Aberrant tolerogenic functions and proinflammatory skew of dendritic cells in STAT1 gain-of-function patients may contribute to autoimmunity and fungal susceptibility.

Clinical immunology (Orlando, Fla.)
2023

Chinese Pedigree of Chronic Mucocutaneous Candidiasis Due to STAT1 Gain-of-Function Mutation: A Case Study and Literature Review.

Mycopathologia
2022

Chronic oral mucocutaneous candidiasis, recurrent respiratory infection, hepatosplenomegaly, and autoimmune diabetes mellitus: A case report of a gain-of-function mutation of STAT1 in a Chinese boy.

Frontiers in pediatrics
2022

Single-cell RNA sequencing combined with whole exome sequencing reveals the landscape of the immune pathogenic response to chronic mucocutaneous candidiasis with STAT1 GOF mutation.

Frontiers in immunology
2022

Immunoprofiling of monocytes in STAT1 gain-of-function chronic mucocutaneous candidiasis.

Frontiers in immunology
2022

CARD9 deficiency predisposing chromoblastomycosis: A case report and comparative transcriptome study.

Frontiers in immunology
2022

Case report: A STAT1 gain-of-function mutation causes a syndrome of combined immunodeficiency, autoimmunity and pure red cell aplasia.

Frontiers in immunology
2022

Gain-of-function STAT1 mutation and visceral leishmaniasis.

Einstein (Sao Paulo, Brazil)
2022

A novel AIRE mutation leads to autoimmune polyendocrine syndrome type-1.

Frontiers in cell and developmental biology
2023

Three Adult Cases of STAT1 Gain-of-Function with Chronic Mucocutaneous Candidiasis Treated with JAK Inhibitors.

Journal of clinical immunology
2022

Lacrimo-auriculo-dento-digital syndrome with AIRE mutation: A case report.

Journal of stomatology, oral and maxillofacial surgery
2022

Main human inborn errors of immunity leading to fungal infections.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
2022

Pearls & Oy-sters: Spinal Cord Candidiasis Linked to CARD9 Deficiency Masquerading as a Longitudinally Extensive Transverse Myelitis.

Neurology
2022

AIRE gene mutation predisposing chronic mucocutaneous candidiasis and pigmented retinitis in two kids from a Chinese family.

Emerging microbes &amp; infections
2022

Efficacy of Cochleated Amphotericin B in Mouse and Human Mucocutaneous Candidiasis.

Antimicrobial agents and chemotherapy
2022

Utility of ruxolitinib in a patient with chronic mucocutaneous candidiasis caused by STAT1 gain-of-function mutation.

Journal of the European Academy of Dermatology and Venereology : JEADV
2022

Clinical and Genetic Characteristics of Ectodermal Dysplasia in Four Indian Children.

Indian journal of dermatology
2022

Chronic mucocutaneous candidiasis, pancytopenia, and systemic mycosis in a patient with STAT1 gene mutation ineffectively treated with ruxolitinib.

Central-European journal of immunology
2022

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and esophageal rupture by candida infection: A case report and review.

Journal de mycologie medicale
2022

CARD9 Deficiency in Combination with Invasive Infection by Exophiala Dermatitidis in a Pediatric Patient.

Mycopathologia
2022

A child with bronchiectasis, chronic mucocutaneous candidiasis, and hypothyroidism secondary to STAT1 gain-of-function mutation: A case report and review of the literature.

Clinical case reports
2022

Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain of Function (GOF) Mutations-10 Children and Review of the Literature.

Journal of clinical immunology
2022

Clinical Characteristics in the Longitudinal Follow-Up of APECED Syndrome in Southern Croatia-Case Series.

Genes
2022

A mycobacterium fortuitum infection in chronic mucocutaneous candidiasis.

Pediatrics international : official journal of the Japan Pediatric Society
2022

Chronic Mucocutaneous Candidiasis due to Signal Transducer and Activator of Transcription 1 (STAT 1) Mutation in an Indian Patient - A Case Report.

Indian dermatology online journal
2022

Oral manifestations of autoimmune polyglandular syndrome type 1.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
2022

CARD9 Regulation and its Role in Cardiovascular Diseases.

International journal of biological sciences
2022

Case Report: Eosinophilic Esophagitis in a Patient With a Novel STAT1 Gain-of-Function Pathogenic Variant.

Frontiers in immunology
2022

Mucocutaneous and cutaneous generalized candidiasis in a thymectomized dog.

Medical mycology case reports
2022

Rheumatologic diseases in patients with inborn errors of immunity in the USIDNET registry.

Clinical rheumatology
2022

[Chronic mucocutaneous candidiasis].

Orvosi hetilap
2022

IL-17 serum level in patients with chronic mucocutaneous candidiasis disease.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
2022

Anticytokine autoantibodies: Autoimmunity trespassing on antimicrobial immunity.

The Journal of allergy and clinical immunology
2021

Case Report: A New Gain-of-Function Mutation of STAT1 Identified in a Patient With Chronic Mucocutaneous Candidiasis and Rosacea-Like Demodicosis: An Emerging Association.

Frontiers in immunology
2021

Chronic tongue pain and alopecia.

Pediatric dermatology
2021

Co-Occurrence of Chronic Mucocutaneous Candidiasis with Woolly Hair.

Skin appendage disorders
2021

Hypoadrenalism as the Single Presentation of Autoimmune Polyglandular Syndrome Type 1.

Journal of the Endocrine Society
2022

CARD9 Expression Pattern, Gene Dosage, and Immunodeficiency Phenotype Revisited.

Journal of clinical immunology
2021

Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy.

Frontiers in pediatrics
2022

Regulation of IL-17A-Producing Cells in Skin Inflammatory Disorders.

The Journal of investigative dermatology
2021

Recurrent Candida-Associated Esophageal Strictures in an Immunocompetent Patient.

ACG case reports journal
2021

[Chronic mucocutaneous candidiasis associated with autoimmunity and ectodermal dysplasia. A case report].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
2021

Candidiasis in patients with APS-1: low IL-17, high IFN-γ, or both?

Current opinion in immunology
2021

Case Report: Disseminated Talaromyces marneffei Infection in a Patient With Chronic Mucocutaneous Candidiasis and a Novel STAT1 Gain-of-Function Mutation.

Frontiers in immunology
2021

Infections in the monogenic autoimmune syndrome APECED.

Current opinion in immunology
2022

Defects of the Innate Immune System and Related Immune Deficiencies.

Clinical reviews in allergy &amp; immunology
2021

Genetic Analysis of a Cohort of 275 Patients with Hyper-IgE Syndromes and/or Chronic Mucocutaneous Candidiasis.

Journal of clinical immunology
2021

Autoimmune polyglandular syndrome type 1 with diabetes insipidus: a case report.

BMC endocrine disorders
2021

Biallelic TRAF3IP2 variants causing chronic mucocutaneous candidiasis in a child harboring a STAT1 variant.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
2021

Characterization of the clinical and genetic spectrum of autoimmune polyendocrine syndrome type 1 in Chinese case series.

Orphanet journal of rare diseases
2021

Case Report: DOCK8 Deficiency Without Hyper-IgE in a Child With a Large Deletion.

Frontiers in pediatrics
2021

The potential role for topical imiquimod in the treatment of chronic mucocutaneous candidiasis caused by gain-of-function mutation in STAT1: A case-report.

Dermatologic therapy
2021

Chronic demodicosis in patients with immune dysregulation: An unexpected infectious manifestation of Signal transducer and activator of transcription (STAT)1 gain-of-function.

Clinical and experimental immunology
2021

Case Report: Rituximab Improved Epileptic Spasms and EEG Abnormalities in an Infant With West Syndrome and Anti-NMDAR Encephalitis Associated With APECED.

Frontiers in neurology
2021

Report of two siblings with APECED in Serbia: is there a founder effect of c.769C>T AIRE genotype?

Italian journal of pediatrics
2021

Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients.

Journal of endocrinological investigation
2021

Clinical, immunological, and genetic features in 938 patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a systematic review.

Expert review of clinical immunology
2021

Atypical presentation of autoimmune polyglandular syndrome type 1 in the fifth decade.

BMJ case reports
2021

A Novel TRAF3IP2 Mutation Causing Chronic Mucocutaneous Candidiasis.

Journal of clinical immunology
2021

Clinical Relevance of Gain- and Loss-of-Function Germline Mutations in STAT1: A Systematic Review.

Frontiers in immunology
2021

Chronic mucocutaneous candidiasis associated with paracoccidioidomycosis in a patient with mannose receptor deficiency: First case reported in the literature.

Revista da Sociedade Brasileira de Medicina Tropical
2021

Autoimmune Addison's Disease as Part of the Autoimmune Polyglandular Syndrome Type 1: Historical Overview and Current Evidence.

Frontiers in immunology
2021

Transcriptional Profiling of STAT1 Gain-of-Function Reveals Common and Mutation-Specific Fingerprints.

Frontiers in immunology
2021

Late-onset autoimmune polyendocrine syndrome type 1: a case report and literature review.

Immunologic research
2020

An AIREless Breath: Pneumonitis Caused by Impaired Central Immune Tolerance.

Frontiers in immunology
2021

Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy in Two Siblings: Same Mutations but Very Different Phenotypes.

Genes
2021

Primary immunodeficiency and chronic mucocutaneous candidiasis: pathophysiological, diagnostic, and therapeutic approaches.

Allergologia et immunopathologia
2021

Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation.

Journal of clinical immunology
2021

Palmoplantar keratoderma with deafness phenotypic variability in a patient with an inherited GJB2 frameshift variant and novel missense variant.

Molecular genetics &amp; genomic medicine
2021

Bronchiectasis and Bronchiolectasis With Severe Herniating Pattern Associated With STAT1 Gain-of-Function Mutation: Detailed Clinicopathological Findings.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2020

Hypoparathyroidism as the single major component for decades of autoimmune polyglandular syndrome type 1.

Endocrinology, diabetes &amp; metabolism case reports
2021

STAT 1 mutation associated with chronic mucocutaneous candidiasis and pancytopenia.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
2021

Chronic Candida infection, bronchiectasis, immunoglobulin abnormalities, and stunting: a case report of a natural mutation of STAT1 (c.986C>G) in an adolescent male.

BMC infectious diseases
2021

Case Report: Dental Findings Can Aid in Early Diagnosis of APECED Syndrome.

Frontiers in dental medicine
2021

Two patients with chronic mucocutaneous candidiasis caused by TRAF3IP2 deficiency.

The Journal of allergy and clinical immunology
2021

A Patient With AIRE Mutation Who Presented With Severe Diarrhea and Lung Abscess.

The Pediatric infectious disease journal
2020

Chronic Mucocutaneous Candidiasis in Early Life: Insights Into Immune Mechanisms and Novel Targeted Therapies.

Frontiers in immunology
2021

A new case of deep dermatophytic disease with inherited CARD9 deficiency.

International journal of dermatology
2020

The pathogenic T387A missense mutation in the gene encoding signal transducer and activator of transcription 1 exhibits a differential gene expression profile.

Molecular immunology
2020

A Case of Critical Lower-Limb Ischemia in a 29-Year-Old Man with Autoimmune Polyglandular Syndrome Type 1 (APS-1).

The American journal of case reports
2020

AAV9-mediated AIRE gene delivery clears circulating antibodies and tissue T-cell infiltration in a mouse model of autoimmune polyglandular syndrome type-1.

Clinical &amp; translational immunology
2020

Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy.

Journal of clinical immunology
2021

Autoimmune polyendocrine syndrome type 1 (APECED) in the Indian population: case report and review of a series of 45 patients.

Journal of endocrinological investigation
2020

A novel variant in AIRE causing a rare, non‑classical autoimmune polyendocrine syndrome type 1.

Molecular medicine reports
2020

An IL-17F.S65L Knock-In Mouse Reveals Similarities and Differences in IL-17F Function in Oral Candidiasis: A New Tool to Understand IL-17F.

Journal of immunology (Baltimore, Md. : 1950)
2020

Live Cell Imaging Demonstrates Multiple Routes Toward a STAT1 Gain-of-Function Phenotype.

Frontiers in immunology
2021

APECED-Associated Hepatitis: Clinical, Biochemical, Histological and Treatment Data From a Large, Predominantly American Cohort.

Hepatology (Baltimore, Md.)
2021

Biological and clinical significance of T helper 17 cell deficiency: insight into monogenic defects.

European annals of allergy and clinical immunology
Ver todos os 380 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Candidíase mucocutânea crônica.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Candidíase mucocutânea crônica

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. IL-17-mediated antifungal immunity restricts Candida albicans pathogenicity in the oral cavity.
    Nature microbiology· 2026· PMID 41387547mais citado
  2. Genotype-Phenotype Delineation of Autoimmune Polyendocrinopathy, Candidiasis, and Ectodermal Dystrophy in a Pediatric Patient: A Case Report.
    Genes· 2026· PMID 41751543mais citado
  3. When One Gland Speaks First: Autoimmune Polyendocrinopathy Syndrome Type 1 (APS-1) Unmasked by Isolated Hypoparathyroidism.
    Cureus· 2026· PMID 41728462mais citado
  4. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a case series and experience from a UK tertiary paediatric hospital.
    Journal of pediatric endocrinology &amp; metabolism : JPEM· 2026· PMID 41712317mais citado
  5. Long-term follow-up of autoimmune polyendocrine syndrome type-1 in Norway.
    The Journal of clinical endocrinology and metabolism· 2026· PMID 41678364mais citado
  6. Selective JAK1 inhibition with upadacitinib controls STAT1 gain-of-function-related hidradenitis suppurativa and chronic mucocutaneous candidiasis.
    Intern Med J· 2026· PMID 41945459recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:1334(Orphanet)
  2. MONDO:0015279(MONDO)
  3. GARD:1077(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q3705799(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Candidíase mucocutânea crônica
Compêndio · Raras BR

Candidíase mucocutânea crônica

ORPHA:1334 · MONDO:0015279
Prevalência
Unknown
Herança
Autosomal dominant, Autosomal recessive
CID-10
B37.2 · Candidíase da pele e das unhas
CID-11
Ensaios
1 ativos
Início
Childhood, Infancy
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0006845
Repurposing
1 candidato
econazolelanosterol demethylase inhibitor|sterol demethylase inhibitor
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades